What Obama’s Plan for ‘Precision Medicine’ Really Means

The president wants to help develop new, more effective drugs.

Prescription Medicine
National Journal
Sam Baker
Add to Briefcase
See more stories about...
Sam Baker
Jan. 20, 2015, 4:12 p.m.

Pres­id­ent Obama used his State of the Uni­on ad­dress Tues­day to launch a new ini­ti­at­ive that would use the hu­man gen­ome to build bet­ter med­ic­al treat­ments.

Obama called it the “Pre­ci­sion Medi­cine Ini­ti­at­ive” — so what’s pre­ci­sion medi­cine, any­way?

In short, it’s one of the most prom­ising and ex­cit­ing fields of med­ic­al re­search. Pre­ci­sion medi­cine, also known as “per­son­al­ized medi­cine,” is about the know­ledge we’ve gained by se­quen­cing the hu­man gen­ome. It’s the ef­fort to turn that know­ledge in­to bet­ter, more ef­fect­ive medi­cines.

“I want the coun­try that elim­in­ated polio and mapped the hu­man gen­ome to lead a new era of medi­cine — one that de­liv­ers the right treat­ment at the right time,” Obama said. “In some pa­tients with cyst­ic fibrosis, this ap­proach has re­versed a dis­ease once thought un­stop­pable.”

The ap­proach is built largely on sci­ence’s im­proved un­der­stand­ing of ge­net­ics. The think­ing, roughly, is that doc­tors will be able to look to pa­tients’ genes to see wheth­er they’re at in­creased risk for cer­tain con­di­tions — mean­ing doc­tors could try to to pre­vent those dis­eases from de­vel­op­ing, or be on the lookout to treat them early if they do de­vel­op.

And by bet­ter un­der­stand­ing each pa­tient’s in­di­vidu­al ill­ness, doc­tors can bet­ter tail­or the right dose of the right medi­cine, at the right time.

Fran­cis Collins, the dir­ect­or of the Na­tion­al In­sti­tutes of Health, is a lead­ing ad­voc­ate for more per­son­al­ized medi­cine. Here’s how he de­scribed it in an in­ter­view last fall:

“If I got a dia­gnos­is of can­cer today, I would want that can­cer to be com­pletely se­quenced, to see what muta­tions are there that are driv­ing those cells to grow when they shouldn’t, and then to be able to use that in­form­a­tion to pick from the cur­rent menu — which is grow­ing rap­idly — of mo­lecu­larly tar­geted drugs.”

Es­pe­cially in terms of ac­tu­ally de­vel­op­ing medi­cines, it’s still a young field. Sci­ent­ists are learn­ing a lot, very quickly, about the un­der­ly­ing ge­net­ic causes of many dis­eases. But the busi­ness of trans­lat­ing that know­ledge in­to more tar­geted treat­ments is still just get­ting star­ted.

That’s what Obama pro­posed jump-start­ing in the State of the Uni­on.

“To­night, I’m launch­ing a new Pre­ci­sion Medi­cine Ini­ti­at­ive to bring us closer to cur­ing dis­eases like can­cer and dia­betes — and to give all of us ac­cess to the per­son­al­ized in­form­a­tion we need to keep ourselves and our fam­il­ies health­i­er,” he planned to say, ac­cord­ing to the pre­pared speech.

He might even be able to find some bi­par­tis­an sup­port, de­pend­ing on the de­tails of the plan. (The pre­pared text didn’t of­fer any more in­form­a­tion.)

The House En­ergy and Com­merce Com­mit­tee, chaired by Rep. Fred Up­ton, is in the midst of an am­bi­tious pro­ject to fig­ure out a bet­ter way to test and ap­prove new drugs. Ahead of Tues­day’s speech, Up­ton praised the co­oper­a­tion he has re­ceived from top Health and Hu­man Ser­vices of­fi­cials, in­clud­ing Sec­ret­ary Sylvia Math­ews Bur­well.

Up­ton’s and Obama’s ini­ti­at­ives aren’t the same — Up­ton’s is about the reg­u­la­tion of new drugs, while the pres­id­ent’s is about their de­vel­op­ment. But, of course, those two things go hand in hand.

What We're Following See More »
RESTROOM ISSUES RETURN
Trump To Rescind Trans Protections
55 minutes ago
THE DETAILS

Donald Trump is planning to reverse an Obama-era order requiring that schools allow students to use the bathroom that coincides with their gender identity. Trump "has green-lighted the plan for the Justice Department and Education Department to send a “Dear Colleague” letter to schools rescinding the guidance." A case is going before the Supreme Court on March 28 in which Gavin Grimm, a transgender high school student, is suing his high school for forbidding him to use the men's room.

Source:
NAIVE, RISK TAKER
Russia Compiling Dossier on Trump’s Mind
2 hours ago
WHY WE CARE

Retired Russian diplomats and members of Vladimir Putin's staff are compiling a dossier "on Donald Trump's psychological makeup" for the Russian leader. "Among its preliminary conclusions is that the new American leader is a risk-taker who can be naïve, according to a senior Kremlin adviser."

Source:
“HORRIBLE” AND “PAINFUL”
Trump Addresses Threats On Jewish Community Centers
3 hours ago
THE DETAILS
COULD COME TUESDAY
Trump Set To Issue New Travel Ban
4 hours ago
THE DETAILS

Donald Trump is set to issue a new and more focused executive order clarifying the scope of his travel ban, hoping that the order will survive legal challenges. The new order would focus on the same seven countries, "but would only bar entry to those without a visa and who have never entered the United States before. Unlike the original order, people from those countries who already have permanent U.S. residency (green cards) or visas would not face any restrictions." Some lawyers believe the government will now have much stronger standing, though lawyers who challenged the initial order see the same core problems with the forthcoming ban.

Source:
KELLOGG WILL RETURN TO NSC COS
Trump Taps Lt. Gen. McMaster as NSC Head
4 hours ago
THE LATEST

"President Donald Trump announced Monday that Lt. Gen. H.R. McMaster will serve as his next national security adviser, filling the void left last week by the sudden dismissal of Michael Flynn. ... Retired Lt. Gen. Keith Kellogg, who had been serving as the acting national security adviser since Flynn's exit, will return to his role as chief of staff of the National Security Council." The pick was widely praised on both sides of the aisle.

Source:
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login